Table 2. Reduction of BP From Baselinea.
Variable | BP in TI Group, mm Hg | BP in UC Group, mm Hg | Differential Change From Baseline, mm Hg | P Valueb | ||
---|---|---|---|---|---|---|
Mean (95% CI) | Reduction From Baseline, Mean (95% CI) | Mean (95% CI) | Reduction From Baseline, Mean (95% CI) | |||
Systolic BP | ||||||
Baseline | 148.2 (146.3 to 150.0) | NA | 147.7 (145.8 to 149.5) | NA | NA | NA |
6 mo | 126.7 (124.4 to 129.0) | −21.5 (−23.9 to −19.1) | 136.9 (134.6 to 139.2) | −10.8 (−13.3 to −8.3) | −10.7 (−14.3 to −7.3) | <.001 |
12 mo | 125.7 (123.4 to 128.0) | −22.5 (−25.1 to −19.9) | 134.8 (132.5 to 137.2) | −12.9 (−15.5 to −10.2) | −9.7 (−13.4 to −6.0) | <.001 |
18 mo | 126.9 (124.3 to 129.4) | −21.3 (−24.2 to −18.4) | 133.0 (130.4 to 135.5) | −14.7 (−17.6 to −11.8) | −6.6 (−10.7 to −2.5) | .004 |
54 mo | 130.6 (128.2 to 133.0) | −17.6 (−20.3 to −15.0) | 132.6 (130.2 to 134.9) | −15.1 (−17.7 to −12.5) | −2.5 (−6.3 to 1.2) | .18 |
Diastolic BP | ||||||
Baseline | 84.4 (82.3 to 86.6) | NA | 85.1 (82.9 to 87.3) | NA | NA | NA |
6 mo | 75.0 (72.9 to 77.2) | −9.4 (−11.1 to −7.6) | 81.7 (79.5 to 84.0) | −3.4 (−5.2 to −1.5) | −6.0 (−8.6 to −3.4) | <.001 |
12 mo | 75.1 (72.8 to 77.4) | −9.3 (−11.0 to −7.7) | 80.8 (78.5 to 83.2) | −4.3 (−5.9 to −2.7) | −5.1 (−7.4 to −2.8) | <.001 |
18 mo | 75.1 (73.0 to 77.2) | −9.3 (−11.7 to −7.0) | 78.7 (76.6 to 80.9) | −6.4 (−8.7 to −3.9) | −3.0 (−6.3 to 0.3) | .07 |
54 mo | 77.5 (75.6 to 79.4) | −7.0 (−8.5 to −5.4) | 79.1 (77.2 to 81.0) | −6.0 (−7.5 to −4.4) | −1.0 (−3.2 to 1.2) | .37 |
Abbreviations: BP, blood pressure; NA, not applicable; TI, telemonitoring intervention; UC, usual care.
Blood pressure results from baseline and 6, 12, and 18 months were previously reported in the study by Margolis et al.15
Calculated using the treatment group by time interaction term, indicating a differential reduction from baseline by study group.